United States: FDA Publishes Guidance On The Identification And Notification Of Suspect Products As Part Of The Implementation Of The Drug Supply Chain Security Act - Winston & Strawn LLP

Earlier this month, the Food and Drug Administration (FDA or the Agency) issued guidance (Guidance) to aid trading partners (manufacturers, repackagers, wholesale distributors, and dispensers)...